{"issuance_frequency":"","notes_translated":{"fr":"La présente ligne directrice a pour objet de définir le Common Technical Document (CTD) de présentations de drogue nouvelle s'appuyant sur des études comparatives de la biodisponibilité afin d'établir l'innocuité et l'efficacité des produits. Cette ligne directrice fait aussi référence à certaines exigences techniques relatives à la réalisation et à l'analyse de ces études.","en":"The purpose of this guidance is to define the Common Technical Document (CTD) format of drug submissions which rely on comparative bioavailability studies to establish safety and efficacy. This guidance also references some of the technical requirements related to the conduct and analysis of such studies."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"ff464180-d153-429e-a665-d9eaa556acc1","metadata_created":"2021-06-01T18:01:45.027557","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-01T18:01:45.027563","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-01","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["directives pour l'industrie","biodisponibilité comparative","présentations de médicaments","document technique commun","format CTD","sécurité et efficacité","Règlement sur les aliments et drogues"],"en":["guidance for industry","comparative bioavailability","drug submissions","common technical document","CTD format","sfety and effectiveness","Food and Drug Regulations"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ébauche ligne directrice à l'intention de l'industrie: Préparation de données comparatives de biodisponibilité pour les présentations de drogues dans le format CTD","en":"Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"ff464180-d153-429e-a665-d9eaa556acc1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b32a9682-c293-4e32-87d0-42b847094141","related_relationship":"","name_translated":{"fr":"Ébauche ligne directrice à l'intention de l'industrie: Préparation de données comparatives de biodisponibilité pour les présentations de drogues dans le format CTD","en":"Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format","language":["en"],"created":"2021-06-01T18:01:45.113005","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/common-technical-document/draft-guidance-industry-preparation-comparative-bioavailability-information-drug-submissions-format.html#a1","last_modified":null,"position":0,"revision_id":"2b1a484b-4707-4c5a-834e-0f2dc17b3455","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"ff464180-d153-429e-a665-d9eaa556acc1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"eccddebc-9eab-4ac4-a71d-76fab17e709c","related_relationship":"","name_translated":{"fr":"Ébauche ligne directrice à l'intention de l'industrie: Préparation de données comparatives de biodisponibilité pour les présentations de drogues dans le format CTD","en":"Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format","language":["fr"],"created":"2021-06-01T18:01:45.113011","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/common-technical-document/directrice-intention-industrie-preparation-donnees-comparatives-biodisponibilite-presentations-drogues-format.html#a1","last_modified":null,"position":1,"revision_id":"2b1a484b-4707-4c5a-834e-0f2dc17b3455","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2011-01-27 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"ff464180-d153-429e-a665-d9eaa556acc1","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The purpose of this guidance is to define the Common Technical Document (CTD) format of drug submissions which rely on comparative bioavailability studies to establish safety and efficacy. This guidance also references some of the technical requirements related to the conduct and analysis of such studies.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format","revision_id":"2b1a484b-4707-4c5a-834e-0f2dc17b3455"}